Concepedia

Author

Agostino Tafuri

Sapienza University of RomeORCID

Also Known As

A Tafuri, A. TAFURI, A. Tafuri, A., Tafuri, AGOSTINO TAFURI, Agostino TAFURI, Agostino Tafuri, Agustino Tafuri, Anna Tafuri, Elisa Scalabrino

387

Publications

17.7K

Citations

53

H-Index

111

Concepts

All Affiliations

Sapienza University of RomeUniversity of BolognaIstituti di Ricovero e Cura a Carattere ScientificoAzienda Ospedaliera Sant'AndreaUniversity of Modena and Reggio Emilia
AT

About

Agostino Tafuri is an author at Sapienza University of Rome specializing in medicine, hematology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

35

1.6K

2

Health Sciences

12

13

778

3

Public Health

2

2

108

4

Natural Sciences

1

1

19

5

Biochemistry

1

1

33

Agostino Tafuri

×

94

Publications

6.4K

Citations

36

H-Index

YearCitations

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

Raymond P. Warrell, Stanley R. Frankel, Wilson H. Miller,

New England Journal of Medicine

1991

1.3K

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini,

The Lancet Haematology

2020

551

Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia

Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli,

Blood

2007

443

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç,

The Lancet Oncology

2019

375

Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias

Maria Rosaria Ricciardi, Simone Mirabilii, Matteo Allegretti,

Blood

2015

215

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni,

Blood

2019

208

Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia

Peter Bettelheim, Peter Valent, Michael Andreeff,

Blood

1991

183

Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro.

Agostino Tafuri, Michael Andreeff

PubMed

1990

154

RETRACTED ARTICLE: MEK inhibition enhances ABT-737-induced leukemia cell apoptosis via prevention of ERK-activated MCL-1 induction and modulation of MCL-1/BIM complex

Marina Konopleva, Michèle Milella, Peter P. Ruvolo,

Leukemia

2011

136

MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia

Agostino Tafuri

Blood

2002

111

Page 1